The NIA IMPACT Collaboratory has announced 2 new funding opportunities to support embedded pragmatic clinical trials (ePCTs) of nonpharmacological interventions within healthcare systems to improve the care of people living with Alzheimer disease and related dementias and their care partners. Applications that address dementia care for people of all backgrounds and that promote health equity are a high priority.
- Career Development Awards: The NIA IMPACT Collaboratory funds 2 to 3 career development awards annually. These awards support the development of early-stage investigators who seek careers conducting ePCTs. Optional informational webinars on April 29 and May 20 will provide prospective applicants with an overview of application details. The webinars will be recorded and posted online. Read the full funding opportunity description.
- Pilot Studies: The NIA IMPACT Collaboratory funds several 1-year pilot studies annually to support the generation of preliminary data necessary to design and conduct a full-scale ePCTs. In response to the COVID-19 public health emergency, this cycle of awards will prioritize applications that propose pilot ePCTs of telemedicine, telehealth, and remote technologies interventions. An optional informational webinar on May 6 will provide prospective applicants with an overview of application details. Read the full funding opportunity description.
The NIA IMPACT Collaboratory is supported by a grant from the National Institute on Aging.
The National Institute on Aging (NIA) Imbedded Pragmatic AD/ADRD Clinical Trials (IMPACT) Collaboratory is soliciting letters of intent for several 1-year pilot grant awards of up to $150,000. The awards will provide funds to pilot projects that aim to generate preliminary data necessary to design and conduct full-scale embedded pragmatic clinical trials of nonpharmacologic interventions in healthcare systems for persons living with Alzheimer disease and related dementias and/or their caregivers.